Use of injection methods in genitourinary syndrome of menopause

Abstract

Genitourinary syndrome of menopause (GSM) is a set of symptoms of atrophy, the main cause of which are evolutive changes in the vulvovaginal and urethral regions. GSM is a common condition affecting up to 90 % of menopausal women. The main symptoms encountered in this syndrome include: dryness of the vulvovaginal area (more than 90 %), dyspareunia (78 %), itching (57 %) and burning (57 %). These symptoms, according to various questionnaires, strongly affect the quality of women’s life, as well as their sexual life. A review of GSM therapy with plasma therapy (PRP) and injection with hyaluronic acid was performed. The clinical observation and the process of managing patients with manifestations of GSM are described in detail. An analysis of the effectiveness and safety of injection techniques in GSM is considered.